Pharmaceuticals and Healthcare Reports 'Optic Neuropathy Market | Page 2

- The report reviews key players involved Optic Neuropathy therapeutics and enlists all their major and minor
projects
- The report assesses Optic Neuropathy therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Optic Neuropathy
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Optic Neuropathy
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Optic Neuropathy pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/optic-neuropathy-pipelinereview-h2-2016/request-sample
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Optic Neuropathy Overview 7
Therapeutics Development 8
Pipeline Products for Optic Neuropathy - Overview 8
Pipeline Products for Optic Neuropathy - Comparative Analysis 9
Optic Neuropathy - Therapeutics under Development by Companies 10
Optic Neuropathy - Therapeutics under Investigation by Universities/Institutes 11
Optic Neuropathy - Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Optic Neuropathy - Products under Development by Companies 15
Optic Neuropathy - Products under Investigation by Universities/Institutes 16
Optic Neuropathy - Companies Involved in Therapeutics Development 17
Amgen Inc. 17
BioAxone BioSciences, Inc. 18
Inotek Pharmaceuticals Corporation 19
Ironwood Pharmaceuticals, Inc. 20
PharmatrophiX, Inc. 21
Quark Pharmaceuticals, Inc. 22
Regenera Phar